Anniina Snellman

Cognitively healthy APOE4/4 carriers show white matter impairment associated with serum NfL and amyloid-PET (2024)

Neurobiology of Disease

Tato-Fernández Claudia, Ekblad Laura L., Pietilä Elina, Saunavaara Virva, Helin Semi, Parkkola Riitta, Zetterberg Henrik, Blennow Kaj, Rinne Juha O., Snellman Anniina

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Midlife insulin resistance, APOE genotype, and change in late-life brain beta-amyloid accumulation : A 5-year follow-up [11C]PIB-PET study (2024)

Neurobiology of Disease

Pietilä Elina, Snellman Anniina, Tuisku Jouni, Helin Semi, Viitanen Matti, Jula Antti, Rinne Juha O., Ekblad Laura L.

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA (2024)

EJNMMI Research

Alzghool Obada M., Aarnio Richard, Helin Jatta S., Wahlroos Saara, Keller Thomas, Matilainen Markus, Solis Junel, Danon Jonathan J., Kassiou Michael, Snellman Anniina, Solin Olof, Rinne Juha O., Haaparanta-Solin Merja

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's Disease (2024)

Molecular Neurodegeneration

Lantero-Rodriguez Juan, Salvado Gemma, Snellman Anniina, Montoliu-Gaya Laia, Brum Wagner S., Benedet Andrea L., Mattsson-Carlgren Niklas, Tideman Pontus, Janelidze Shorena, Palmqvist Sebastian, Stomrud Erik, Ashton Nicholas J., Zetterberg Henrik, Blennow Kaj, Hansson Oskar

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Plasma Biomarker Strategy for Selecting Patients With Alzheimer Disease for Antiamyloid Immunotherapies (2024)

JAMA Neurology

Mattsson-Carlgren Niklas, Collij Lyduine E., Stomrud Erik, Binette Alexa Pichet, Ossenkoppele Rik, Smith Ruben, Karlsson Linda, Lantero-Rodriguez Juan, Snellman Anniina, Strandberg Olof, Palmqvist Sebastian, Ashton Nicholas J., Blennow Kaj, Janelidze Shorena, Hansson Oskar

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Correction to: Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA (EJNMMI Research, (2024), 14, 1, (25), 10.1186/s13550-024-01085-7) (2024)

EJNMMI Research

(Muu (O2))

CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease (2024)

Acta Neuropathologica

Lantero-Rodriguez J., Montoliu-Gaya L., Benedet A.L., Vrillon A., Dumurgier J., Cognat E., Brum W.S., Rahmouni N., Stevenson J., Servaes S., Therriault J., Becker B., Brinkmalm G., Snellman A., Huber H., Kvartsberg H., Ashton N.J., Zetterberg H., Paquet C., Rosa-Neto P., Blennow K.

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Sex-driven variability in TSPO-expressing microglia in MS patients and healthy individuals (2024)

Frontiers in Neurology

Laaksonen Sini, Saraste Maija, Nylund Marjo, Hinz Rainer, Snellman Anniina, Rinne Juha, Matilainen Markus, Airas Laura

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Head-to-head comparison of plasma p-tau181, p-tau231 and glial fibrillary acidic protein in clinically unimpaired elderly with three levels of APOE4-related risk for Alzheimer's disease (2023)

Neurobiology of Disease

Snellman Anniina, Ekblad Laura L., Ashton Nicholas J., Karikari Thomas K., Lantero-Rodriguez Juan, Pietilä Elina, Koivumäki Mikko, Helin Semi, Karrasch Mira, Zetterberg Henrik, Blennow Kaj, Rinne Juha O.

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly (2023)

Alzheimer's Research and Therapy

Snellman Anniina, Ekblad Laura L., Tuisku Jouni, Koivumäki Mikko, Ashton Nicholas J., Lantero-Rodriguez Juan, Karikari Thomas K., Helin Semi, Bucci Marco, Löyttyniemi Eliisa, Parkkola Riitta, Karrasch Mira, Schöll Michael, Zetterberg Henrik, Blennow Kaj, Rinne Juha O.

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Contact

Links

Publications

Sort by:

Cognitively healthy APOE4/4 carriers show white matter impairment associated with serum NfL and amyloid-PET (2024)

Midlife insulin resistance, APOE genotype, and change in late-life brain beta-amyloid accumulation : A 5-year follow-up [11C]PIB-PET study (2024)

Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA (2024)

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's Disease (2024)

Plasma Biomarker Strategy for Selecting Patients With Alzheimer Disease for Antiamyloid Immunotherapies (2024)

Correction to: Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA (EJNMMI Research, (2024), 14, 1, (25), 10.1186/s13550-024-01085-7) (2024)

CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease (2024)

Sex-driven variability in TSPO-expressing microglia in MS patients and healthy individuals (2024)

Head-to-head comparison of plasma p-tau181, p-tau231 and glial fibrillary acidic protein in clinically unimpaired elderly with three levels of APOE4-related risk for Alzheimer's disease (2023)

APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly (2023)